Abstract
A novel complex, formulated as [Cu2(μ3-SO4)2(C4H6N2)4], showed significant ameliorative effects on tumor osteolytic lesions in malignant Walker 256/B breast cancer-induced bone metastases.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have